Loading…

A cancer of undetermined significance: Incidental thyroid carcinoma

Introduction The incidence of thyroid cancer is increasing which can be attributed in part to improved ultrasonography (US) methods and increased detection of incidental thyroid carcinomas (ITC). We aimed to compare ITC with nonincidental thyroid carcinomas (NITC) in this study. Methods Retrospectiv...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic cytopathology 2019-05, Vol.47 (5), p.412-416
Main Authors: Evranos, Berna, Polat, Sefika Burcak, Cuhaci, Fatma Neslihan, Baser, Husniye, Topaloglu, Oya, Kilicarslan, Aydan, Kilic, Mehmet, Ersoy, Reyhan, Cakir, Bekir
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3497-75e0f36124937d6963c4cad1869516de749cc54dd7726dfa987e75db934630c23
cites cdi_FETCH-LOGICAL-c3497-75e0f36124937d6963c4cad1869516de749cc54dd7726dfa987e75db934630c23
container_end_page 416
container_issue 5
container_start_page 412
container_title Diagnostic cytopathology
container_volume 47
creator Evranos, Berna
Polat, Sefika Burcak
Cuhaci, Fatma Neslihan
Baser, Husniye
Topaloglu, Oya
Kilicarslan, Aydan
Kilic, Mehmet
Ersoy, Reyhan
Cakir, Bekir
description Introduction The incidence of thyroid cancer is increasing which can be attributed in part to improved ultrasonography (US) methods and increased detection of incidental thyroid carcinomas (ITC). We aimed to compare ITC with nonincidental thyroid carcinomas (NITC) in this study. Methods Retrospective analyses of 906 individual patients who were operated for benign and malignant thyroid disease and had a final histopathological diagnosis of thyroid carcinoma were enrolled in this study. Preoperative US examination and fine needle aspiration (FNA) biopsy results were evaluated. The tumor foci in thyroidectomy specimens that were not represented in preoperative US or FNA reports were classified as ITC. The tumor foci that match with the lesions defined in US or FNA results were classified as NITC. Results Final histology revealed ITC in 326 patients (36%) and NITC in 580 patients (64% Mean age was 51.7 ± 11.11 in ITC group and 48.15 ± 13.1 in NITC group (P 
doi_str_mv 10.1002/dc.24117
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2139567930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2202773979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3497-75e0f36124937d6963c4cad1869516de749cc54dd7726dfa987e75db934630c23</originalsourceid><addsrcrecordid>eNp1kM1LwzAYxoMobk7Bv0AKXrx0vvlo0ngb9Wsw8KLn0CWpZrTpTFpk_711mzsInt7D-3t-PDwIXWKYYgBya_SUMIzFERpjkCIFSuUxGuciy1IMVI7QWYwrAJAE81M0osDynAsYo2KW6NJrG5K2SnpvbGdD47w1SXTv3lVu-71L5l47Y31X1kn3sQmtM0MuaOfbpjxHJ1VZR3uxvxP09vjwWjyni5eneTFbpJqyoZTILFSUY8IkFYZLTjXTpcE5lxnmxgomtc6YMUIQbqpS5sKKzCwlZZyCJnSCbnbedWg_exs71biobV2X3rZ9VARTmXEhKQzo9R901fbBD-0UIUCEoHLgDkId2hiDrdQ6uKYMG4VB_QyrjFbbYQf0ai_sl401B_B3yQFId8CXq-3mX5G6L3bCb4lLfl8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2202773979</pqid></control><display><type>article</type><title>A cancer of undetermined significance: Incidental thyroid carcinoma</title><source>Wiley</source><creator>Evranos, Berna ; Polat, Sefika Burcak ; Cuhaci, Fatma Neslihan ; Baser, Husniye ; Topaloglu, Oya ; Kilicarslan, Aydan ; Kilic, Mehmet ; Ersoy, Reyhan ; Cakir, Bekir</creator><creatorcontrib>Evranos, Berna ; Polat, Sefika Burcak ; Cuhaci, Fatma Neslihan ; Baser, Husniye ; Topaloglu, Oya ; Kilicarslan, Aydan ; Kilic, Mehmet ; Ersoy, Reyhan ; Cakir, Bekir</creatorcontrib><description><![CDATA[Introduction The incidence of thyroid cancer is increasing which can be attributed in part to improved ultrasonography (US) methods and increased detection of incidental thyroid carcinomas (ITC). We aimed to compare ITC with nonincidental thyroid carcinomas (NITC) in this study. Methods Retrospective analyses of 906 individual patients who were operated for benign and malignant thyroid disease and had a final histopathological diagnosis of thyroid carcinoma were enrolled in this study. Preoperative US examination and fine needle aspiration (FNA) biopsy results were evaluated. The tumor foci in thyroidectomy specimens that were not represented in preoperative US or FNA reports were classified as ITC. The tumor foci that match with the lesions defined in US or FNA results were classified as NITC. Results Final histology revealed ITC in 326 patients (36%) and NITC in 580 patients (64% Mean age was 51.7 ± 11.11 in ITC group and 48.15 ± 13.1 in NITC group (P < .001). In NITC group 322 (55.5%) of the patients were operated for suspicious cytology while only 29 (8.9%) of the patients in the ITC group were operated because of this indication (P < .001). There were 1301 cancer foci in histopathology specimens. Among all these cancer foci, 434 (33.3%) were detected incidentally and 867 (66.7%) were detected non‐incidentally. About 779 (89.9%) of nonincidental cancer foci were papillary cancer (PTC), while all of the incidental cancer foci were PTC. Mean size was 13 mm in NITC group and it was 3 mm in the ITC group and differed significantly between the groups (P < .001). Tumor size was ≤1 cm in 35.2% of the patients with NITC while 98.5% of patients with ITC had tumor ≤1 cm. The occurrence of multinodularity was higher in ITC than the NITC group (P < 001). Median TSH level was higher in patients with NITC than ITC while both were in the reference range (1.53 vs 1.03 μIU/mL, P < .001). The frequency of thyroiditis detected by US, and thyroid peroxidase antibody and thyroglobulin antibody positivities were similar in patients with ITC and NITC (P = .2, P = .86, and P = .26, respectively). The frequencies of capsular invasion (29.1% vs 7.9%), extrathyroidal extension (13% vs 4.2%), multifocality (35.8% vs 24.2%), non‐complete resection (9.2% vs 1.8%), and lymph node metastasis (9.5% vs 1.8%) were significantly higher in the NITC group (P < .001, for each). Persistent/recurrent disease in patients with NITC was more frequent than patients with ITC (P = .004). This outcome was similar for cancers measuring ≤1 cm (P = .001). Conclusion ITC is often encountered in older patients and frequently determined in early stages with more favorable histopathological features and better prognosis.]]></description><identifier>ISSN: 8755-1039</identifier><identifier>EISSN: 1097-0339</identifier><identifier>DOI: 10.1002/dc.24117</identifier><identifier>PMID: 30488670</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Biopsy ; Cytology ; Histology ; Histopathology ; incidental thyroid cancer ; Iodide peroxidase ; Lesions ; Lymph nodes ; Metastases ; non‐incidental thyroid cancer ; Peroxidase ; Thyroglobulin ; Thyroid cancer ; Thyroid carcinoma ; Thyroid diseases ; Thyroid-stimulating hormone ; Thyroidectomy ; Thyroiditis</subject><ispartof>Diagnostic cytopathology, 2019-05, Vol.47 (5), p.412-416</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3497-75e0f36124937d6963c4cad1869516de749cc54dd7726dfa987e75db934630c23</citedby><cites>FETCH-LOGICAL-c3497-75e0f36124937d6963c4cad1869516de749cc54dd7726dfa987e75db934630c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30488670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Evranos, Berna</creatorcontrib><creatorcontrib>Polat, Sefika Burcak</creatorcontrib><creatorcontrib>Cuhaci, Fatma Neslihan</creatorcontrib><creatorcontrib>Baser, Husniye</creatorcontrib><creatorcontrib>Topaloglu, Oya</creatorcontrib><creatorcontrib>Kilicarslan, Aydan</creatorcontrib><creatorcontrib>Kilic, Mehmet</creatorcontrib><creatorcontrib>Ersoy, Reyhan</creatorcontrib><creatorcontrib>Cakir, Bekir</creatorcontrib><title>A cancer of undetermined significance: Incidental thyroid carcinoma</title><title>Diagnostic cytopathology</title><addtitle>Diagn Cytopathol</addtitle><description><![CDATA[Introduction The incidence of thyroid cancer is increasing which can be attributed in part to improved ultrasonography (US) methods and increased detection of incidental thyroid carcinomas (ITC). We aimed to compare ITC with nonincidental thyroid carcinomas (NITC) in this study. Methods Retrospective analyses of 906 individual patients who were operated for benign and malignant thyroid disease and had a final histopathological diagnosis of thyroid carcinoma were enrolled in this study. Preoperative US examination and fine needle aspiration (FNA) biopsy results were evaluated. The tumor foci in thyroidectomy specimens that were not represented in preoperative US or FNA reports were classified as ITC. The tumor foci that match with the lesions defined in US or FNA results were classified as NITC. Results Final histology revealed ITC in 326 patients (36%) and NITC in 580 patients (64% Mean age was 51.7 ± 11.11 in ITC group and 48.15 ± 13.1 in NITC group (P < .001). In NITC group 322 (55.5%) of the patients were operated for suspicious cytology while only 29 (8.9%) of the patients in the ITC group were operated because of this indication (P < .001). There were 1301 cancer foci in histopathology specimens. Among all these cancer foci, 434 (33.3%) were detected incidentally and 867 (66.7%) were detected non‐incidentally. About 779 (89.9%) of nonincidental cancer foci were papillary cancer (PTC), while all of the incidental cancer foci were PTC. Mean size was 13 mm in NITC group and it was 3 mm in the ITC group and differed significantly between the groups (P < .001). Tumor size was ≤1 cm in 35.2% of the patients with NITC while 98.5% of patients with ITC had tumor ≤1 cm. The occurrence of multinodularity was higher in ITC than the NITC group (P < 001). Median TSH level was higher in patients with NITC than ITC while both were in the reference range (1.53 vs 1.03 μIU/mL, P < .001). The frequency of thyroiditis detected by US, and thyroid peroxidase antibody and thyroglobulin antibody positivities were similar in patients with ITC and NITC (P = .2, P = .86, and P = .26, respectively). The frequencies of capsular invasion (29.1% vs 7.9%), extrathyroidal extension (13% vs 4.2%), multifocality (35.8% vs 24.2%), non‐complete resection (9.2% vs 1.8%), and lymph node metastasis (9.5% vs 1.8%) were significantly higher in the NITC group (P < .001, for each). Persistent/recurrent disease in patients with NITC was more frequent than patients with ITC (P = .004). This outcome was similar for cancers measuring ≤1 cm (P = .001). Conclusion ITC is often encountered in older patients and frequently determined in early stages with more favorable histopathological features and better prognosis.]]></description><subject>Biopsy</subject><subject>Cytology</subject><subject>Histology</subject><subject>Histopathology</subject><subject>incidental thyroid cancer</subject><subject>Iodide peroxidase</subject><subject>Lesions</subject><subject>Lymph nodes</subject><subject>Metastases</subject><subject>non‐incidental thyroid cancer</subject><subject>Peroxidase</subject><subject>Thyroglobulin</subject><subject>Thyroid cancer</subject><subject>Thyroid carcinoma</subject><subject>Thyroid diseases</subject><subject>Thyroid-stimulating hormone</subject><subject>Thyroidectomy</subject><subject>Thyroiditis</subject><issn>8755-1039</issn><issn>1097-0339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kM1LwzAYxoMobk7Bv0AKXrx0vvlo0ngb9Wsw8KLn0CWpZrTpTFpk_711mzsInt7D-3t-PDwIXWKYYgBya_SUMIzFERpjkCIFSuUxGuciy1IMVI7QWYwrAJAE81M0osDynAsYo2KW6NJrG5K2SnpvbGdD47w1SXTv3lVu-71L5l47Y31X1kn3sQmtM0MuaOfbpjxHJ1VZR3uxvxP09vjwWjyni5eneTFbpJqyoZTILFSUY8IkFYZLTjXTpcE5lxnmxgomtc6YMUIQbqpS5sKKzCwlZZyCJnSCbnbedWg_exs71biobV2X3rZ9VARTmXEhKQzo9R901fbBD-0UIUCEoHLgDkId2hiDrdQ6uKYMG4VB_QyrjFbbYQf0ai_sl401B_B3yQFId8CXq-3mX5G6L3bCb4lLfl8</recordid><startdate>201905</startdate><enddate>201905</enddate><creator>Evranos, Berna</creator><creator>Polat, Sefika Burcak</creator><creator>Cuhaci, Fatma Neslihan</creator><creator>Baser, Husniye</creator><creator>Topaloglu, Oya</creator><creator>Kilicarslan, Aydan</creator><creator>Kilic, Mehmet</creator><creator>Ersoy, Reyhan</creator><creator>Cakir, Bekir</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201905</creationdate><title>A cancer of undetermined significance: Incidental thyroid carcinoma</title><author>Evranos, Berna ; Polat, Sefika Burcak ; Cuhaci, Fatma Neslihan ; Baser, Husniye ; Topaloglu, Oya ; Kilicarslan, Aydan ; Kilic, Mehmet ; Ersoy, Reyhan ; Cakir, Bekir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3497-75e0f36124937d6963c4cad1869516de749cc54dd7726dfa987e75db934630c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biopsy</topic><topic>Cytology</topic><topic>Histology</topic><topic>Histopathology</topic><topic>incidental thyroid cancer</topic><topic>Iodide peroxidase</topic><topic>Lesions</topic><topic>Lymph nodes</topic><topic>Metastases</topic><topic>non‐incidental thyroid cancer</topic><topic>Peroxidase</topic><topic>Thyroglobulin</topic><topic>Thyroid cancer</topic><topic>Thyroid carcinoma</topic><topic>Thyroid diseases</topic><topic>Thyroid-stimulating hormone</topic><topic>Thyroidectomy</topic><topic>Thyroiditis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evranos, Berna</creatorcontrib><creatorcontrib>Polat, Sefika Burcak</creatorcontrib><creatorcontrib>Cuhaci, Fatma Neslihan</creatorcontrib><creatorcontrib>Baser, Husniye</creatorcontrib><creatorcontrib>Topaloglu, Oya</creatorcontrib><creatorcontrib>Kilicarslan, Aydan</creatorcontrib><creatorcontrib>Kilic, Mehmet</creatorcontrib><creatorcontrib>Ersoy, Reyhan</creatorcontrib><creatorcontrib>Cakir, Bekir</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic cytopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evranos, Berna</au><au>Polat, Sefika Burcak</au><au>Cuhaci, Fatma Neslihan</au><au>Baser, Husniye</au><au>Topaloglu, Oya</au><au>Kilicarslan, Aydan</au><au>Kilic, Mehmet</au><au>Ersoy, Reyhan</au><au>Cakir, Bekir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A cancer of undetermined significance: Incidental thyroid carcinoma</atitle><jtitle>Diagnostic cytopathology</jtitle><addtitle>Diagn Cytopathol</addtitle><date>2019-05</date><risdate>2019</risdate><volume>47</volume><issue>5</issue><spage>412</spage><epage>416</epage><pages>412-416</pages><issn>8755-1039</issn><eissn>1097-0339</eissn><abstract><![CDATA[Introduction The incidence of thyroid cancer is increasing which can be attributed in part to improved ultrasonography (US) methods and increased detection of incidental thyroid carcinomas (ITC). We aimed to compare ITC with nonincidental thyroid carcinomas (NITC) in this study. Methods Retrospective analyses of 906 individual patients who were operated for benign and malignant thyroid disease and had a final histopathological diagnosis of thyroid carcinoma were enrolled in this study. Preoperative US examination and fine needle aspiration (FNA) biopsy results were evaluated. The tumor foci in thyroidectomy specimens that were not represented in preoperative US or FNA reports were classified as ITC. The tumor foci that match with the lesions defined in US or FNA results were classified as NITC. Results Final histology revealed ITC in 326 patients (36%) and NITC in 580 patients (64% Mean age was 51.7 ± 11.11 in ITC group and 48.15 ± 13.1 in NITC group (P < .001). In NITC group 322 (55.5%) of the patients were operated for suspicious cytology while only 29 (8.9%) of the patients in the ITC group were operated because of this indication (P < .001). There were 1301 cancer foci in histopathology specimens. Among all these cancer foci, 434 (33.3%) were detected incidentally and 867 (66.7%) were detected non‐incidentally. About 779 (89.9%) of nonincidental cancer foci were papillary cancer (PTC), while all of the incidental cancer foci were PTC. Mean size was 13 mm in NITC group and it was 3 mm in the ITC group and differed significantly between the groups (P < .001). Tumor size was ≤1 cm in 35.2% of the patients with NITC while 98.5% of patients with ITC had tumor ≤1 cm. The occurrence of multinodularity was higher in ITC than the NITC group (P < 001). Median TSH level was higher in patients with NITC than ITC while both were in the reference range (1.53 vs 1.03 μIU/mL, P < .001). The frequency of thyroiditis detected by US, and thyroid peroxidase antibody and thyroglobulin antibody positivities were similar in patients with ITC and NITC (P = .2, P = .86, and P = .26, respectively). The frequencies of capsular invasion (29.1% vs 7.9%), extrathyroidal extension (13% vs 4.2%), multifocality (35.8% vs 24.2%), non‐complete resection (9.2% vs 1.8%), and lymph node metastasis (9.5% vs 1.8%) were significantly higher in the NITC group (P < .001, for each). Persistent/recurrent disease in patients with NITC was more frequent than patients with ITC (P = .004). This outcome was similar for cancers measuring ≤1 cm (P = .001). Conclusion ITC is often encountered in older patients and frequently determined in early stages with more favorable histopathological features and better prognosis.]]></abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30488670</pmid><doi>10.1002/dc.24117</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 8755-1039
ispartof Diagnostic cytopathology, 2019-05, Vol.47 (5), p.412-416
issn 8755-1039
1097-0339
language eng
recordid cdi_proquest_miscellaneous_2139567930
source Wiley
subjects Biopsy
Cytology
Histology
Histopathology
incidental thyroid cancer
Iodide peroxidase
Lesions
Lymph nodes
Metastases
non‐incidental thyroid cancer
Peroxidase
Thyroglobulin
Thyroid cancer
Thyroid carcinoma
Thyroid diseases
Thyroid-stimulating hormone
Thyroidectomy
Thyroiditis
title A cancer of undetermined significance: Incidental thyroid carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A03%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20cancer%20of%20undetermined%20significance:%20Incidental%20thyroid%20carcinoma&rft.jtitle=Diagnostic%20cytopathology&rft.au=Evranos,%20Berna&rft.date=2019-05&rft.volume=47&rft.issue=5&rft.spage=412&rft.epage=416&rft.pages=412-416&rft.issn=8755-1039&rft.eissn=1097-0339&rft_id=info:doi/10.1002/dc.24117&rft_dat=%3Cproquest_cross%3E2202773979%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3497-75e0f36124937d6963c4cad1869516de749cc54dd7726dfa987e75db934630c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2202773979&rft_id=info:pmid/30488670&rfr_iscdi=true